Literature DB >> 11254752

Vesicle-binding properties of wild-type and cysteine mutant forms of alpha(1) domain of apolipoprotein B.

J A DeLozier1, J S Parks, G S Shelness.   

Abstract

Previous studies demonstrated that structural perturbation of the alpha(1) domain of apolipoprotein B (apoB) blocked the initiation of lipoprotein assembly. We explored the hypothesis that this domain may interact with the inner leaflet of the endoplasmic reticulum membrane in a manner that may nucleate microsomal triglyceride transfer protein-dependent lipid sequestration. ApoB-17 (amino-terminal 17% of apoB), which contains most of the alpha(1) domain, was expressed stably in rat hepatoma cells and recovered from medium in lipid-poor form. On incubation with phospholipid vesicles composed of 1-myristol-2-myristoyl-sn-glycero-3-phosphocholine or 1-palmitoyl-2-oleoyl-sn-gylycero-3-phosphocholine, apoB-17 underwent vesicle binding and was recovered in the d < 1.25 g/ml gradient fraction. To determine whether vesicle binding is disrupted by the same structural perturbations that block lipoprotein assembly in vivo, apoB-17 was subjected to partial and complete chemical reduction. Although normally a soluble peptide, mild reduction of apoB-17 caused its precipitation, suggesting that hydrophobic, solvent-inaccessible domains within the alpha(1) domain of apoB are stabilized by intramolecular disulfide bonds. In contrast to apoB-17 chemically reduced in vitro, forms of apoB-17 bearing pairwise cysteine-to-serine substitutions were recovered in soluble form from transiently transfected COS-1 cell extracts. Although individual disruption of disulfide bond 2 or 4 in apoB-28 and apoB-50 was previously shown to block lipoprotein assembly in vivo, these alterations had no impact on the ability of apoB-17 to bind to phospholipid vesicles in vitro or on its capacity to form recombinant lipoprotein particles. These results suggest that while the vesicle/lipid-binding property of the alpha(1) domain may reflect an essential role required for the initiation of lipoprotein formation, some other aspect of alpha(1) domain function is perturbed by disruption of native disulfide bonds. -- DeLozier, J. A., J. S. Parks, and G. S. Shelness. Vesicle-binding properties of wild-type and cysteine mutant forms of alpha(1) domain of apolipoprotein B. J. Lipid Res. 2001. 42: 399--406.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254752

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  4 in total

1.  Defining lipid-interacting domains in the N-terminal region of apolipoprotein B.

Authors:  Zhenghui Gordon Jiang; Donald Gantz; Esther Bullitt; C James McKnight
Journal:  Biochemistry       Date:  2006-10-03       Impact factor: 3.162

2.  Structural analysis of reconstituted lipoproteins containing the N-terminal domain of apolipoprotein B.

Authors:  Zhenghui Gordon Jiang; Martha N Simon; Joseph S Wall; C James McKnight
Journal:  Biophys J       Date:  2007-03-16       Impact factor: 4.033

3.  Structural and dynamic interfacial properties of the lipoprotein initiating domain of apolipoprotein B.

Authors:  Aubrey S Ledford; Victoria A Cook; Gregory S Shelness; Richard B Weinberg
Journal:  J Lipid Res       Date:  2008-08-18       Impact factor: 5.922

4.  Protein disulfide isomerases contribute differentially to the endoplasmic reticulum-associated degradation of apolipoprotein B and other substrates.

Authors:  Sarah Grubb; Liang Guo; Edward A Fisher; Jeffrey L Brodsky
Journal:  Mol Biol Cell       Date:  2011-12-21       Impact factor: 4.138

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.